Department of Pharmaceutical and Administrative Sciences, University of Health Science and Pharmacy in St Louis, St. Louis, MO, USA.
Department of Nutrition and Dietetics, Ondokuz Mayis University, Samsun, Turkey.
Int J Obes (Lond). 2023 Nov;47(11):1108-1119. doi: 10.1038/s41366-023-01365-7. Epub 2023 Aug 18.
Obesity is considered one of the most crucial health problems of the century. Therefore, reducing obesity is critically important. Caffeine (CF) and chlorogenic acid (CLA), which are substantial components in green bean coffee which maximize thermogenesis in brown adipose tissue. In our study, we have prepared CF, CLA, and CF + CLA loaded-solid lipid nanoparticles (SLN) since the SLNs are cost-effective, tissue-localized, and highly stable. The central composite design model was preferred to select the optimized formulation. UHPLC was used for quantification related to the CF and CLA amounts. The high-pressure homogenization (HPH) method was used while SLN formulations were prepared in the presence of poloxamer® 407 (surfactant) and Compritol® 888 ATO (solid lipid). The nanoparticles were characterized, followed by the utilization of 3T3-F442A cell lines for the evaluation of the adipogenesis activity of the formulations. Then, rt-PCR and ELISA studies of adipogenic markers were conducted. After optimal formulations were selected with an average of 110.2 ± 0.1 nm, CF (1 mM) + CLA (0.5 mM)-loaded SLN formulation has been proven significantly effective by using PPAR-γ/C/EBP-a pathways. In a nutshell, our study has shown that CF + CLA loaded-SLN has been affected 45.8% times more than regular extracted coffee (p < 0.05) on the adipocyte cells.
肥胖被认为是本世纪最重要的健康问题之一。因此,减少肥胖至关重要。咖啡因 (CF) 和绿原酸 (CLA) 是咖啡豆中的主要成分,可以最大限度地促进棕色脂肪组织的产热。在我们的研究中,我们已经制备了 CF、CLA 和 CF+CLA 负载的固体脂质纳米粒 (SLN),因为 SLN 具有成本效益、组织定位和高度稳定性。我们选择了中心复合设计模型来选择优化的配方。使用 UHPLC 定量 CF 和 CLA 的含量。在高压匀质 (HPH) 法的存在下制备 SLN 配方,同时使用泊洛沙姆® 407(表面活性剂)和 Compritol® 888 ATO(固体脂质)。对纳米粒进行了表征,然后使用 3T3-F442A 细胞系评估制剂的脂肪生成活性。然后,进行了脂肪生成标记物的 rt-PCR 和 ELISA 研究。在选择平均粒径为 110.2±0.1nm 的最佳配方后,CF(1mM)+CLA(0.5mM)负载的 SLN 制剂已通过 PPAR-γ/C/EBP-a 途径被证明具有显著的效果。简而言之,我们的研究表明,CF+CLA 负载的 SLN 对脂肪细胞的影响比普通提取咖啡高 45.8%(p<0.05)。